Non steroidal anti-inflammatory drugs (NSAIDs; such as aspirin and ibuprofen) can help reduce symptoms of low back pain that doesn’t involve sciatica, a Cochrane Systematic Review has found.
Low back pain is a major health problem in western industrialised countries, but there is little conclusive evidence about the best ways to treat it. NSAIDs are the most frequently prescribed medication worldwide, and are commonly given to people with low back pain. The hope is that they will not only reduce pain symptoms, but also reduce any inflammation in the back that may be the cause of the pain.
To evaluate the effectiveness of these drugs, Cochrane Researchers considered data from 65 trials that met their inclusion criteria. These involved a total of 11,237 people. They found that:
- NSAIDs were more effective at reducing pain than placebos, although the effects were small and NSAIDs were associated with more adverse effects.
- Different types of NSAID appeared to be equally effective.
- Short-term use of selective COX-2 inhibitors had fewer (gastrointestinal) side effects than the other NSAIDs.
The researchers also compared the effects of NSAIDs and paracetamol, another drug used by people with low back pain. They concluded that NSAIDs and paracetamol were equally effective at relieving acute low back pain, but paracetamol had fewer side effects.
“Physicians and patients with acute low back pain therefore have a choice about whether to use a NSAID or paracetamol, and the decision should be driven by individual clinical circumstances,” says lead author Pepijn Roelofs who works in the Department of general Practice at Erasmus University Medical Centre, Rotterdam, Netherlands.
“Most of these results came from studies of people who did not have sciatica, so we now need studies that look at whether NSAIDs have a role in helping those people as well,” says Roelofs
Source: Wiley-Blackwell
Related stories:
New clinical guideline for low-back pain
A summary of evidence on the diagnosis and treatment of low-back pain has prompted the American Pain Society (ASP) and the American College of Physicians (ACP) to issue a new treatment guideline. The guideline is based on a thorough analysis of published research conducted by investigators at the Oregon Evidence-Based Practice Center at Oregon Health & Science University.
Ibuprofen puts high risk cardiac patients at risk
Doctors who treat the painful condition of osteoarthritis in patients with increased cardiovascular risk need to be cautious. A team lead by researchers at Mount Sinai School of Medicine, are the first to study outcomes in high cardiovascular risk patients with osteoarthritis. The researchers compared combination treatments of low-dose aspirin with the drugs ibuprofen, naproxen and the cox-2 inhibitor lumiracoxib.
At risk for peripheral arterial disease? Simple quiz provides key so you can circulate better
Ten million Americans have peripheral arterial disease (PAD), and research shows that the highest risk populations include African-Americans (twice as likely to develop clogged leg arteries), seniors (12-20 percent develop PAD) and diabetics (one in three who are over the age of 50 develop PAD). Legs for Life®—a community health and public information program—recommends that older Americans take its free, online self-assessment quiz.
Researchers offer first direct proof of how osteoarthritis destroys cartilage
A team of orthopaedic researchers has found definitive, genetic proof of how the most common form of arthritis destroys joint cartilage in nearly 21 million aging Americans, according to a study published online Sept. 2 in the
Journal of Bone and Mineral Research. The findings serve as an important foundation for the design of new treatments for osteoarthritis (OA), researchers said.
Positive exercise testing in athletes: What does that mean?
Sudden cardiac death (SCD) during sports activity is an uncommon, but catastrophic event. Different efforts to reduce the risk of SCD related to sports have been undertaken. What is the role of the exercise test in this context? What does a positive exercise test mean?
New test to diagnose osteoarthritis early
A newly developed medical imaging technology may provide doctors with a long-awaited test for early diagnosis of osteoarthritis (OA), scientists from New York reported today at the 236th National Meeting of the American Chemical Society. By far the most common form of arthritis, OA is a bane of the Baby Boom generation, causing joint pain and disability for more than half of those over 65 – nearly 21 million people in the United States.
Researchers discover how rheumatoid arthritis causes bone loss
Researchers have discovered key details of how rheumatoid arthritis (RA) destroys bone, according to a study published in the Aug. 22 edition of the
Journal of Biological Chemistry. The findings are already guiding attempts to design new drugs to reverse RA-related bone loss and may also address more common forms of osteoporosis with a few adjustments.
A molecule keeps anxiety down
(PhysOrg.com) -- The link between emotions and experiences determines many aspects of our daily life. It allows us to recognize pretty objects or harmful situations. These links are created when nerve cells construct new connections to one another or reinforce existing connections. Scientists at the Max Planck Institutes for Neurobiology and Psychiatry and at the Großhadern Clinic (Ludwig Maximilian University) have now discovered a molecule with a crucial influence on the strength of these connections (
PNAS, August 4, 2008).